EXACT THERAPEUTICS AS PROVIDES STRATEGIC BUSINESS UPDATE
Plans to recommence enrolment in the ACTIVATE clinical trial and new trial in pancreatic cancer in the US.
OSLO/LONDON: 18 NOVEMBER, 2021: Exact Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today announces a number of strategic, operational and scientific developments.
